Evidence map›Paper›PMID 28236327›Full record

ArticleJournal of clinical laboratory analysis2018

Analytical evaluation of the ADAMS

Eloísa Urrechaga

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Analytical evaluation of the ADAMSJournal of clinical laboratory analysis · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Eloísa UrrechagaHospital Galdakao - Usansolo, Galdakao, Vizcaya, Spain.ORCID http://orcid.org/0000-0002-9610-7392
Hospital de Galdakao · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ADAMS

methodsTrueness, imprecision, carry over, linearity, the effect of anemia and correlation with ADAMS

resultsThe results were found to be accurate (total error of 1.74%) and precise: within-run, between-run, between-day and total coefficients of variation were 0.71%, 0.77%, 0.36%, and 0.93% at low concentrations, and 0.43%, 0.29%, 0%, and 0.48% at high concentrations of HbA1c. Carry over, linearity, and correlation of methods were excellent. HbA1c measurement was independent of total Hb concentration in a range 40-214 g/L, and shows no interference from Hb chemically modified commonly observed in this type of analysis, while common Hb variants are detected.

conclusionThe analyzer is a suitable system for glycemic control in patients with diabetes and the detection of Hb variants.

Indexed as

CalibrationChromatography, High Pressure LiquidDiabetes MellitusGlycated HemoglobinHematologic TestsHumansLinear ModelsReproducibility of ResultsSensitivity and SpecificityGlycated HemoglobindiabetesHA-8180T analyzerHbA1cHPLC

Identifiers

PMID28236327
PMCPMC6816950
OpenAlexW2589505595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.